Xuemin
Xuemin Chi, Foothill Ranch, CA US
Patent application number | Description | Published |
---|---|---|
20160125606 | Ultra-Low Power, Ultra High Thruput (ULTRA2) ASIC-based Cognitive Processor - There has been a significant advance in the capabilities of electro-optical sensors to search wide areas and provide data streams that contain information critical to system operators. The problem being addressed by this invention is the accurate and timely interpretation of the observations made by these sensor suites and the instantiation of the processing on practical low power, high throughput processors which enable deployment on a wide variety of platforms. The interpretation of sensor observations will also depend upon a) the general situation, e.g. level of hostility, and b) collateral data, e.g. normal or abnormal operations of the platforms themselves. Can accurate and timely situation awareness be achieved? Yes, humans do it all the time. Can it be done on small, ultra-low power, ultra-high throughput processors? Yes 3D stacked analog ASIC circuits enable such processors. | 05-05-2016 |
Xuemin Ma, Shenzhen CN
Patent application number | Description | Published |
---|---|---|
20140108520 | METHOD AND SYSTEM FOR SEAMLESS WEBPAGE BROWSING - Various embodiments provide methods and systems for seamlessly browsing a webpage from a first browser client to a second browser client. When the first browser client receives a pre-set browser event, a webpage address of a webpage opened by the first browser client can be obtained. The webpage address can then be sent to a server and then obtained from the server when the second browser client is opened. The webpage corresponding to the webpage address can be obtained and outputted through the second browser client. When the second browser client is a mobile terminal browser, a persistent connection can be pre-established between the second browser client and the server, so that the webpage address can be quickly obtained from the server to improve the speed of seamlessly browsing the webpage. | 04-17-2014 |
20160112340 | METHOD AND SYSTEM FOR RESOURCE SHARING - A resource sharing method is provided. The method includes obtaining a user identifier that logs in a current device through a resource sharing operation. The method also includes extracting corresponding binding device information from a server based on the user identifier and displaying the binding device information. Further, the method includes obtaining a device identifier selected from the displayed binding device information and sending the selected device identifier and resource to be shared with a device corresponding to the selected device identifier to the server, such that the server delivers the resource to be shared to the corresponding device based on the selected device identifier. | 04-21-2016 |
Xuemin Zhang, Beijing CN
Patent application number | Description | Published |
---|---|---|
20140066604 | MOLECULAR MARKER CUEDC2 PROTEIN FOR PROGNOSTIC DETERMINATION OF BREAST CANCER ENDOCRINOLOGY THERAPY - Disclosed is a use of the CUEDC2 protein in the preparation of diagnostic agents for prognostic determination of the endocrinology therapy for the breast cancer patients and for the diagnosis of tumor such as breast cancer and ovarian cancer. The diagnostic agent comprises an antibody against the CUEDC2 protein, wherein the antibody is a monoclonal or polyclonal antibody against the CUEDC2 protein. Provided is a kit or a composition for prognostic determination of endocrinology therapy for the breast cancer patients and for the diagnosis of tumors such as breast cancer and ovarian cancer. The kit or composition comprises an antibody against the CUEDC2 protein. Further disclosed is a use of the CUEDC2 gene or protein in preparation of drugs for treating tumors, that is, small molecular substances and specific antibodies that specifically inhibit the expression or activity of the CUEDC2 gene\protein are used as a therapeutic agent to restore the sensitivity of drug-resistant tumors to drug treatment. The new use of the CUEDC2 protein provides a new basis for determining a dosage regimen of adjuvant therapy after surgical operation of the breast cancer patients, thereby improving the therapeutic effect of the anti-cancer drugs and alleviating the suffering and economic burden of the patients. | 03-06-2014 |